来自Craibiodendron yunnanense的Grayananene二烯酸,具有抗炎和抗性感受活性
1Yunnan Institute of Materia Medica, Kunming, 650111, PR China; Yunnan Province Company Key Laboratory for TCM and Ethnic Drug of New Drug Creation, Kunming, 650111, PR China.
Phytochemistry
|May 29, 2023
概括
来自Craibiodendron yunnanense叶的六种新型灰二烯酸体显示出抗炎和抗感受性特性. 一些化合物显著抑制了互白素-6的释放,并减少了疼痛反应.
科学领域:
- 自然产品 化学 化学
- 药理学 药理学是指药理学的学科.
背景情况:
- Craibiodendron yunnanense是一种生物活性化合物的植物来源.
- 灰色二烯酸是一种具有多种生物活动的自然产品类.
研究的目的:
- 从Craibiodendron yunnanense中分离和表征灰色的二类植物.
- 评估这些化合物的抗炎和抗受体活性.
主要方法:
- 使用色谱技术分离化合物.
- 使用1D-NMR,2D-NMR和HR-ESI-MS进行结构阐明.
- 在体外抗炎测定使用脂聚糖 (LPS) 诱导的RAW264.7细胞来测量干白素-6 (IL-6) 抑制.
- 在体内使用乙酸诱导的曲试验进行抗受体测试.
主要成果:
- 他们分离了25种格拉亚南二特类物质,其中包括6种新化合物 (craibiodenoside A-F).
- 克莱比奥登酸A,B,F和三个已知的化合物显著抑制了IL-6的释放.
- 克莱比奥登酸D,格莱亚诺酸D和罗多日素VI表现出显著的抗受体活性.
- 罗多日宁VI在抗受体测试中显示出高抑制率87.6%,在抗受体测试中达到87.6%.
结论:
- 这项研究成功地从C. yunnanense.中分离并鉴定出了新型的灰色状二.
- 一些孤立的化合物,特别是craibiodenoside A,B,F和rhodojaponins VI,具有显著的抗炎和抗性感受潜力.
- 这些发现凸显了来自C. yunnanense的格拉亚南特类药物的治疗承诺,用于炎症和疼痛管理.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
205
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
205
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
328
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
328
Opioid Analgesics: Morphine and Other Natural Cogeners
306
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
306
Opioid Analgesics: Synthetic and Semisynthetic Opioids
351
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
351
Analgesia and Pain Management
673
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
673
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
210
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
210


